- Home
- FNWB vs TLSA Comparison
FNWB vs TLSA Comparison
Compare FNWB & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- TLSA
- Stock Information
- Founded
- FNWB 1923
- TLSA 2013
- Country
- FNWB United States
- TLSA United Kingdom
- Employees
- FNWB N/A
- TLSA N/A
- Industry
- FNWB Banks
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- FNWB Finance
- TLSA Health Care
- Exchange
- FNWB Nasdaq
- TLSA Nasdaq
- Market Cap
- FNWB 95.2M
- TLSA 87.8M
- IPO Year
- FNWB 2015
- TLSA 2000
- Fundamental
- Price
- FNWB $10.17
- TLSA $1.48
- Analyst Decision
- FNWB Hold
- TLSA
- Analyst Count
- FNWB 1
- TLSA 0
- Target Price
- FNWB $12.00
- TLSA N/A
- AVG Volume (30 Days)
- FNWB 28.8K
- TLSA 1.4M
- Earning Date
- FNWB 04-24-2025
- TLSA 05-09-2025
- Dividend Yield
- FNWB 2.79%
- TLSA N/A
- EPS Growth
- FNWB N/A
- TLSA N/A
- EPS
- FNWB N/A
- TLSA N/A
- Revenue
- FNWB $50,900,000.00
- TLSA N/A
- Revenue This Year
- FNWB $42.48
- TLSA N/A
- Revenue Next Year
- FNWB $11.60
- TLSA N/A
- P/E Ratio
- FNWB N/A
- TLSA N/A
- Revenue Growth
- FNWB N/A
- TLSA N/A
- 52 Week Low
- FNWB $8.91
- TLSA $0.41
- 52 Week High
- FNWB $15.90
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- FNWB 38.42
- TLSA 64.75
- Support Level
- FNWB $9.92
- TLSA $1.25
- Resistance Level
- FNWB $10.61
- TLSA $1.59
- Average True Range (ATR)
- FNWB 0.29
- TLSA 0.25
- MACD
- FNWB -0.07
- TLSA 0.03
- Stochastic Oscillator
- FNWB 26.04
- TLSA 61.26
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.